Paediatric Clinical Trials London, England, UK 20-21 March 2017

Description:
Strengthening strategies in paediatric investigation plans remains paramount and with the EMA 10 year review of paediatric regulation a call has been made for greater guidance with the goal of increasing the number of safe paediatric therapeutics on the market.

Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. Gain information on methods to improve clinical recruitment, appreciate ethical issues and navigate regulations when planning and executing a paediatric clinical trial. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.

• Gain an in-depth update from the EMA on the PDCO’s 10 year review into paediatric investigation plans
• Review and discuss paediatric clinical trial legislation in the EU and US
• Join GSK in reviewing the challenges in paediatric drug development for rare diseases
• Hear Roche discuss how clinical outcome assessments can lead to patient - centred paediatric clinical trials
• Optimise your approach to paediatric drug formulation to improve clinical success

Prices:
Conference only: GBP 1499,
Workshop only: GBP 599,
Conference + Workshop: GBP 2098

Speakers: Genetech, Roche, Otsuka Europe, GSK, Roche, Johnson & Johnson, Insys Therapeutics